{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:57:03Z","timestamp":1791928623866,"version":"4.3.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1681\/asn.2010070691","type":"journal-article","created":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T00:19:41Z","timestamp":1300407581000},"page":"782-790","source":"Crossref","is-referenced-by-count":74,"title":["Copeptin Levels Associate with Cardiovascular Events in Patients with ESRD and Type 2 Diabetes Mellitus"],"prefix":"10.1681","volume":"22","author":[{"given":"Wiebke","family":"Fenske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Allolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Drechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Lilienthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Krane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20230423","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2362.2006.01724.x","article-title":"Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure","volume":"36","author":"Stoiser","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"R2-25-20230423","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1373\/clinchem.2009.125856","article-title":"Prognostic value of emerging neurohormones in chronic heart failure during optimization of heart failure-specific therapy","volume":"56","author":"Neuhold","year":"2010","journal-title":"Clin Chem"},{"key":"R3-25-20230423","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"R5-25-20230423","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1172\/JCI118044","article-title":"Vasopressin resistance in chronic renal failure. Evidence for the role of decreased V2 receptor mRNA","volume":"96","author":"Teitelbaum","year":"1995","journal-title":"J Clin Invest"},{"key":"R6-25-20230423","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM196905222802101","article-title":"Vasopressin-resistant hyposthenuria in advanced chronic renal disease","volume":"280","author":"Tannen","year":"1969","journal-title":"N Engl J Med"},{"key":"R7-25-20230423","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI109072","article-title":"Functional profile of the isolated uremic nephron. Impaired water permeability and adenylate cyclase responsiveness of the cortical collecting tubule to vasopressin","volume":"61","author":"Fine","year":"1978","journal-title":"J Clin Invest"},{"key":"R8-25-20230423","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"R9-25-20230423","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jacc.2008.03.050","article-title":"Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: Prediction of death at different stages of the disease","volume":"52","author":"Neuhold","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R10-25-20230423","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cardfail.2008.07.231","article-title":"C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction","volume":"14","author":"Kelly","year":"2008","journal-title":"J Card Fail"},{"key":"R11-25-20230423","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00380-008-1086-1","article-title":"Plasma levels of copeptin in patients with coronary heart disease","volume":"24","author":"Chai","year":"2009","journal-title":"Heart Vessels"},{"key":"R12-25-20230423","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cca.2008.09.016","article-title":"Use of copeptin in the detection of myocardial ischemia","volume":"399","author":"Staub","year":"2009","journal-title":"Clin Chim Acta"},{"key":"R13-25-20230423","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ana.21783","article-title":"Copeptin: A novel, independent prognostic marker in patients with ischemic stroke","volume":"66","author":"Katan","year":"2009","journal-title":"Ann Neurol"},{"key":"R14-25-20230423","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","article-title":"Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data","volume":"367","author":"Lopez","year":"2006","journal-title":"Lancet"},{"key":"R15-25-20230423","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: Clinical features and associations with anticoagulant therapy","volume":"12","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"key":"R16-25-20230423","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/eurheartj\/ehn278","article-title":"Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients","volume":"29","author":"Winkler","year":"2008","journal-title":"Eur Heart J"},{"key":"R17-25-20230423","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ki.2008.484","article-title":"Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis","volume":"74","author":"Krane","year":"2008","journal-title":"Kidney Int"},{"key":"R18-25-20230423","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1161\/01.STR.21.12.1689","article-title":"Endothelium-independent contractions of human cerebral arteries in response to vasopressin","volume":"21","author":"Martin de Aguilera","year":"2009","journal-title":"Stroke"},{"key":"R19-25-20230423","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1152\/ajpcell.1994.266.3.C654","article-title":"Vasoconstrictive peptides induce endothelin-1 and prostanoids in human cerebromicrovascular endothelium","volume":"266","author":"Spatz","year":"1994","journal-title":"Am J Physiol"},{"key":"R20-25-20230423","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1152\/ajpcell.00093.2009","article-title":"Cerebral microvascular endothelial cell Na\/H exchange: Evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin","volume":"297","author":"Lam","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"R21-25-20230423","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.STR.23.12.1767","article-title":"Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats","volume":"23","author":"Rosenberg","year":"1992","journal-title":"Stroke"},{"key":"R22-25-20230423","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","article-title":"Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease","volume":"309","author":"Holmberg","year":"1983","journal-title":"N Engl J Med"},{"key":"R23-25-20230423","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/CIRCULATIONAHA.109.857268","article-title":"Glycemic control and cardiovascular events in diabetic hemodialysis patients","volume":"120","author":"Drechsler","year":"2009","journal-title":"Circulation"},{"key":"R24-25-20230423","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2215\/CJN.04571007","article-title":"The challenge of sudden death in dialysis patients","volume":"3","author":"Ritz","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R25-25-20230423","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0002-9343(87)90228-2","article-title":"Vasopressin as vasopressor","volume":"82","author":"Goldsmith","year":"1982","journal-title":"Am J Med"},{"key":"R26-25-20230423","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1006980517557","article-title":"Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor","volume":"195","author":"Fukuzawa","year":"1999","journal-title":"Mol Cell Biochem"},{"key":"R27-25-20230423","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.ki.5002571","article-title":"Development of renin expression in the mouse kidney","volume":"73","author":"Sauter","year":"2008","journal-title":"Kidney Int"},{"key":"R28-25-20230423","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/01.CIR.83.6.2111","article-title":"Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels","volume":"83","author":"Maturi","year":"1991","journal-title":"Circulation"},{"key":"R29-25-20230423","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.12.010","article-title":"RALES, EPHESUS and redox","volume":"93","author":"Funder","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R30-25-20230423","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats","volume":"47","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"R31-25-20230423","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"Guder","year":"2007","journal-title":"Circulation"},{"key":"R32-25-20230423","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R33-25-20230423","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R34-25-20230423","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/eurheartj\/ehp098","article-title":"C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: Results from the OPTIMAAL study","volume":"30","author":"Voors","year":"2009","journal-title":"Eur Heart J"},{"key":"R35-25-20230423","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/eurjhf\/hfp206","article-title":"The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: Data from the GISSI-heart failure (GISSI-HF) trial","volume":"12","author":"Masson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"R36-25-20230423","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.106.685503","article-title":"C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study","volume":"115","author":"Khan","year":"2007","journal-title":"Circulation"},{"key":"R37-25-20230423","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cardfail.2006.09.004","article-title":"Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure","volume":"13","author":"Gegenhuber","year":"2007","journal-title":"J Card Fail"},{"key":"R38-25-20230423","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2009.397","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort","volume":"77","author":"Meijer","year":"2009","journal-title":"Kidney Int"},{"key":"R39-25-20230423","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/TP.0b013e3181b11ae4","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients","volume":"88","author":"Meijer","year":"2009","journal-title":"Transplantation"},{"key":"R40-25-20230423","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20080140","article-title":"Gender and renal function influence plasma levels of copeptin in healthy individuals","volume":"116","author":"Bhandari","year":"2009","journal-title":"Clin Sci (Lond"},{"key":"R41-25-20230423","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.2337\/dc08-2168","article-title":"Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes","volume":"32","author":"Maier","year":"2009","journal-title":"Diabetes Care"},{"key":"R42-25-20230423","first-page":"1079","article-title":"Platelet vasopressin receptor in patients with chronic renal failure","volume":"31","author":"Inaba","year":"1989","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"R43-25-20230423","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","article-title":"Non-peptide arginine-vasopressin antagonists: The vaptans","volume":"371","author":"Decaux","year":"2008","journal-title":"Lancet"},{"key":"R44-25-20230423","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2215\/CJN.02020408","article-title":"Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis","volume":"4","author":"Krane","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201104000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:33:32Z","timestamp":1786131212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201104000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2010070691","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}